Terlipressin use and respiratory failure in patients with hepatorenal syndrome type 1 and severe acute‐on‐chronic liver failure

BACKGROUND: Previous studies suggested increased mortality in patients with hepatorenal syndrome type 1 (HRS1) and advanced acute‐on‐chronic liver failure (ACLF). AIM: To assess mortality and respiratory failure (RF) in patients with HRS1 and ACLF treated with terlipressin. METHODS: In the CONFIRM s...

Descripción completa

Detalles Bibliográficos
Autores principales: Wong, Florence, Pappas, Stephen Chris, Reddy, K. Rajender, Vargas, Hugo, Curry, Michael P., Sanyal, Arun, Jamil, Khurram
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Terlipressin in Hepatorenal Syndrome Type 1
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804971/
https://www.ncbi.nlm.nih.gov/pubmed/35995728
http://dx.doi.org/10.1111/apt.17195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9804971/
https://www.ncbi.nlm.nih.gov/pubmed/35995728
http://dx.doi.org/10.1111/apt.17195

Ejemplares similares